PLSE:NSC-Pulse Biosciences Inc (USD)

EQUITY | Medical Instruments & Supplies | NASDAQ Capital Market

Last Closing

USD 16.89

Change

0.00 (0.00)%

Market Cap

USD 0.08B

Volume

0.15M

Analyst Target

USD 16.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Pulse Biosciences Inc is a development stage medical device company using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling or NPES for biomedical applications.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-26 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
ISRG Intuitive Surgical Inc

+10.65 (+1.97%)

USD 192.29B
COO The Cooper Companies, Inc

+1.76 (+2.23%)

USD 16.58B
ALGN Align Technology Inc

+7.75 (+4.54%)

USD 13.32B
HOLX Hologic Inc

+7.89 (+14.54%)

USD 12.07B
RGEN Repligen Corporation

+4.39 (+3.72%)

USD 7.71B
MMSI Merit Medical Systems Inc

+1.12 (+1.17%)

USD 5.65B
ICUI ICU Medical Inc

+1.45 (+1.12%)

USD 3.40B
XRAY Dentsply Sirona Inc

+0.87 (+5.62%)

USD 3.17B
LMAT LeMaitre Vascular Inc

+1.28 (+1.57%)

USD 2.07B
ATRC AtriCure Inc

+1.28 (+3.91%)

USD 1.65B

ETFs Containing PLSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange (NASDAQ Capital Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.99% 65% D 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.99% 65% D 54% F
Trailing 12 Months  
Capital Gain 48.55% 88% B+ 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 48.55% 88% B+ 88% B+
Trailing 5 Years  
Capital Gain 70.95% 78% C+ 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 70.95% 78% C+ 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 78.98% 90% A- 92% A
Dividend Return 78.98% 90% A- 92% A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 137.35% 19% F 15% F
Risk Adjusted Return 57.51% 93% A 83% B
Market Capitalization 0.08B 74% C 76% C+

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Instruments & Supplies) Ratio vs. Market (NASDAQ Capital Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A
Price/Book Ratio 10.49 13% 12%
Price / Cash Flow Ratio -35.67 92% 93%
Price/Free Cash Flow Ratio -1.81 83% 77%
Management Effectiveness  
Return on Equity -67.31% 35% 26%
Return on Invested Capital -3.36% 52% 47%
Return on Assets -36.70% 23% 14%
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.